Late toxicity in survivors from adolescent cancers.
Nowadays three quarters of adolescents with cancer are cured but half of them experience a late toxic effect of antineoplastic therapy that interferes with their physical and psychosocial health. This review recapitulates late effects associated with radiation therapy, chemotherapy and surgery, reviews risk factors and prognosis and suggests follow-up and management strategies, excluding fertility issues. Adolescents with cancer should be the focus of active clinical research for the optimisation of antineoplastic treatment as well as for breakthroughs in the follow-up, prevention and management of toxic effects.
Pentheroudakis
George
G
Department of Medical Oncology, Ioannina University Hospital, Niarxou Avenue, 45500 Ioannina, Greece.
Pavlidis
Nicholas
N
D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000139:chemically induced / Q000453:epidemiology*; D014943:Global Health; D006801:Humans; D015994:Incidence; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality; D012307:Risk Factors; D015996:Survival Rate
D000970:Antineoplastic Agents